Zymosan Particle-Induced Hemodynamic, Cytokine and Blood Cell Changes in Pigs: An Innate Immune Stimulation Model with Relevance to Cytokine Storm Syndrome and Severe COVID-19
Open Access
- 6 January 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1138
Abstract
Hemodynamic disturbance, a rise in neutrophil-to-lymphocyte ratio (NLR) and release of inflammatory cytokines into blood, is a bad prognostic indicator in severe COVID-19 and other diseases involving cytokine storm syndrome (CSS). The purpose of this study was to explore if zymosan, a known stimulator of the innate immune system, could reproduce these changes in pigs. Pigs were instrumented for hemodynamic analysis and, after i.v. administration of zymosan, serial blood samples were taken to measure blood cell changes, cytokine gene transcription in PBMC and blood levels of inflammatory cytokines, using qPCR and ELISA. Zymosan bolus (0.1 mg/kg) elicited transient hemodynamic disturbance within minutes without detectable cytokine or blood cell changes. In contrast, infusion of 1 mg/kg zymosan triggered maximal pulmonary hypertension with tachycardia, lasting for 30 min. This was followed by a transient granulopenia and then, up to 6 h, major granulocytosis, resulting in a 3–4-fold increase in NLR. These changes were paralleled by massive transcription and/or rise in IL-6, TNF-alpha, CCL-2, CXCL-10, and IL-1RA in blood. There was significant correlation between lymphopenia and IL-6 gene expression. We conclude that the presented model may enable mechanistic studies on late-stage COVID-19 and CSS, as well as streamlined drug testing against these conditions.Keywords
Funding Information
- European Union Horizon 2020 Projects (825828, 952520, 2020-1.1.6-JÖVŐ-2021-00013, K134939, BO/00304/20/5, ÚNKP-22-5/202206201434KG)
- National Research, Development, and Innovation Office (NKFIH) of Hungary (825828, 952520, 2020-1.1.6-JÖVŐ-2021-00013, K134939, BO/00304/20/5, ÚNKP-22-5/202206201434KG)
- Bolyai Scholarship of the Hungarian Academy of Sciences (825828, 952520, 2020-1.1.6-JÖVŐ-2021-00013, K134939, BO/00304/20/5, ÚNKP-22-5/202206201434KG)
- ÚNKP Bolyai+ Scholarship from the Hungarian Ministry of Innovation and Technology and National Research, Development, and Innovation Office (825828, 952520, 2020-1.1.6-JÖVŐ-2021-00013, K134939, BO/00304/20/5, ÚNKP-22-5/202206201434KG)
This publication has 96 references indexed in Scilit:
- Experimental Model of Zymosan‐Induced Arthritis in the Rat Temporomandibular Joint: Role of Nitric Oxide and NeutrophilsBioMed Research International, 2011
- Hydrogen Gas Improves Survival Rate and Organ Damage in Zymosan-Induced Generalized Inflammation ModelShock, 2010
- Staphylococcal Superantigen (TSST-1) Mutant Analysis Reveals that T Cell Activation Is Required for Biological Effects in the Rabbit Including the Cytokine StormToxins, 2010
- Zymosan, but Not Lipopolysaccharide, Triggers Severe and Progressive Peritoneal Injury Accompanied by Complement Activation in a Rat Peritonitis ModelThe Journal of Immunology, 2009
- Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactionsBlood, 2008
- Structure of the fungal β‐glucan‐binding immune receptor dectin‐1: Implications for functionProtein Science, 2007
- IL-6 blocks a discrete early step in lymphopoiesisBlood, 2005
- Macrophage recognition of zymosan particlesInnate Immunity, 2003
- Dectin-1 Is A Major β-Glucan Receptor On MacrophagesJournal of Experimental Medicine, 2002
- Tumour Necrosis Factor Alpha (TNF‐α) and Interleukin 6 in a Zymosan‐Induced Shock ModelScandinavian Journal of Immunology, 1990